Alamar
Country not established
- Devices
- 7
What Alamar makes
Alamar manufactures antimicrobial susceptibility test panels and individual antimicrobial agents, including cefoperazone, ceftriaxone, and imipenem, designed for laboratory use in identifying bacterial resistance patterns. These products support diagnostic testing to guide antibiotic treatment decisions by evaluating microbial responses to specific antimicrobials.
The company’s portfolio is regulated as Class II medical devices under FDA 510(k) clearance requirements. These products are listed in the FDA’s 510(k) database and are intended for use in the United States.
Catalogue
Antimicrobial Cefoperazone Ref K910345
Regimes: 510(k) Registry: 510(k)- Regimes: 510(k) Registry: 510(k)
Antimicrobial Susceptibility Test Panel Ref K910484
Regimes: 510(k) Registry: 510(k)Antimicrobial Suscept. Test Panel (Ceftizoxime) Ref K911391
Regimes: 510(k) Registry: 510(k)- Regimes: 510(k) Registry: 510(k)
Antimicrobial Suscept. Test Panel(Trimethoprim) Ref K911390
Regimes: 510(k) Registry: 510(k)Antimicrobial Ceftriaxone Ref K910346
Regimes: 510(k) Registry: 510(k)
Frequently asked questions
How many devices does Alamar have in the registry?
The registry currently lists 7 devices for Alamar. Devices recorded under merged duplicate company entries are counted once.
Which registries list Alamar's devices?
Among its 7 most recently registered devices, Alamar has devices listed in FDA 510(k) (7 devices).
What risk classes do Alamar's devices fall under?
Among its 7 most recently registered devices, the classes recorded for Alamar's devices are Class II. Each device page shows its own class and authorisation.
What are the newest devices from Alamar in the registry?
The most recently registered devices listed for Alamar include ANTIMICROBIAL CEFOPERAZONE, ANTIMICROBIAL SUSCEPTIBILITY TEST PANEL (IMIPENEM), ANTIMICROBIAL SUSCEPTIBILITY TEST PANEL and ANTIMICROBIAL SUSCEPT. TEST PANEL (CEFTIZOXIME).